在下一代测序时代的BCR::ABL1阴性骨髓增殖性新生瘤

Aleksandra Mroczkowska-Bękarciak1, Tomasz Wróbel1

  • 1Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wrocław, Poland.

Frontiers in genetics
|September 25, 2023
PubMed
概括

下一代测序 (NGS) 推进了BCR::ABL1-阴性髓增殖性新生瘤 (MPNs) 的诊断. 先进的分子技术有助于风险分层和对这些克隆性血液癌症的治疗选择.